Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the non-inferiority of switching to the FTC/RPV/TAF FDC as compared to continuing EFV/FTC/TDF FDC in virologically suppressed HIV-1 infected subjects as determined by maintaining HIV-1 RNA < 50 copies/mL at Week 48 (FDA Snapshot Algorithm).
Critère d'inclusion
- Human Immunodeficiency Virus (HIV-1) Infection